You have accessJournal of UrologyUrothelial Cancer: Medical & Surgical Therapy1 Apr 2013530 WILDTYPE REOVIRUS AS NOVEL ONCOLYTIC THERAPEUTIC APPROACH IN TRANSITIONAL CELL CARCINOMA Saladin Helmut Alloussi, Banek Severine, Jörg Hennenlotter, Jens Mundhenk, Christian Schwentner, Ullrich Lauer, and Arnulf Stenzl Saladin Helmut AlloussiSaladin Helmut Alloussi Neunkirchen, Germany More articles by this author , Banek SeverineBanek Severine Regensburg, Germany More articles by this author , Jörg HennenlotterJörg Hennenlotter Tübingen, Germany More articles by this author , Jens MundhenkJens Mundhenk Tübingen, Germany More articles by this author , Christian SchwentnerChristian Schwentner Tübingen, Germany More articles by this author , Ullrich LauerUllrich Lauer Tübingen, Germany More articles by this author , and Arnulf StenzlArnulf Stenzl Tübingen, Germany More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.1924AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Reoviridae are non-human pathogenic viruses. The family of reoviridae consists of 4 different subtypes. Many studies have proven that the Dearing subtype 3 has oncolytic potential. This potential is apparently related to the RAS protein expression in tumour cells. The aim of this study was to investigate whether all reovirus subtypes have oncolytic potential and whether there are differences in their efficacy, in particular for transitional cell carcinoma. METHODS To evaluate the oncolytic potential, we performed an in vitro head-to-head study for all reovirus subtypes in 12 primary cell cultures of transitional cell carcinoma (TCC). We investigated whether all four wildtype reovirus strains would infect and lyse human TCC cell lines in vitro. 12 different TCC cell lines as well as primary fibroblast and primary urothelial cell lines were examined. Oncolytic effects were quantified as cytopathic effect after light microscopical inspection. Besides, a standardized SRB-Assay was performed to investigate the quantitative cell lyses kinetics. A positive oncolyses was determined as cytopathological effect of at least grade II as well as a death rate of at least 50% of the cells for the SRB-Assay. RESULTS Oncolytic activity was detected for all four reovirus strains in 11 (91.67%) of 12 established urothelial cancer cell lines in qualitative and quantitative analyses. This positive oncolytical effect was seen 72 to 96 h after infection. Interindividually there were statistically significant differences observed, however no virus subtype was superior to the others. As expected, there was no cell lyses in fibroblasts after 96 hours. Interestingly, primary urothelial cells stopped in growing; however a relevant cytopathological effect was not detected. The quantitative oncolytic potential differed in relation to the single observed cell culture and in relation to the chosen reovirus subtype. CONCLUSIONS To our knowledge, this is the first study showing oncolytic activity for all reovirus subtypes TCC cell lines. Efficacy of the different subtypes is interindividually different and cannot be forecast. However the different reovirus strains may be a potentially useful treatment for urothelial cancer. This was underlined by the fact, that all strains didn't infect fibroblasts and healthy urothelial cells significantly. This selectivity could help to develop new therapy option. However further studies are necessary to prove the efficacy in vivo. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e217 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Saladin Helmut Alloussi Neunkirchen, Germany More articles by this author Banek Severine Regensburg, Germany More articles by this author Jörg Hennenlotter Tübingen, Germany More articles by this author Jens Mundhenk Tübingen, Germany More articles by this author Christian Schwentner Tübingen, Germany More articles by this author Ullrich Lauer Tübingen, Germany More articles by this author Arnulf Stenzl Tübingen, Germany More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract